Direct-acting Antiviral Drugs and Forecast Market
1 Introduction to Research & Analysis Reports
1.1 Direct-acting Antiviral Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Direct-acting Antiviral Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Direct-acting Antiviral Drugs Overall Market Size
2.1 Global Direct-acting Antiviral Drugs Market Size: 2021 VS 2028
2.2 Global Direct-acting Antiviral Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Direct-acting Antiviral Drugs Players in Global Market
3.2 Top Global Direct-acting Antiviral Drugs Companies Ranked by Revenue
3.3 Global Direct-acting Antiviral Drugs Revenue by Companies
3.4 Top 3 and Top 5 Direct-acting Antiviral Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Direct-acting Antiviral Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Direct-acting Antiviral Drugs Players in Global Market
3.6.1 List of Global Tier 1 Direct-acting Antiviral Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Direct-acting Antiviral Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Direct-acting Antiviral Drugs Market Size Markets, 2021 & 2028
4.1.2 NS3/4A Protease Inhibitors
4.1.3 Nucleoside and Nucleotide NS5B Polymerase Inhibitors
4.1.4 NS5A Inhibitors
4.1.5 Non-Nucleoside NS5B Polymerase Inhibitors
4.2 By Type - Global Direct-acting Antiviral Drugs Revenue & Forecasts
4.2.1 By Type - Global Direct-acting Antiviral Drugs Revenue, 2017-2022
4.2.2 By Type - Global Direct-acting Antiviral Drugs Revenue, 2023-2028
4.2.3 By Type - Global Direct-acting Antiviral Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Direct-acting Antiviral Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Ambulatory Surgical Centers
5.1.5 Pharmacies
5.1.6 Others
5.2 By Application - Global Direct-acting Antiviral Drugs Revenue & Forecasts
5.2.1 By Application - Global Direct-acting Antiviral Drugs Revenue, 2017-2022
5.2.2 By Application - Global Direct-acting Antiviral Drugs Revenue, 2023-2028
5.2.3 By Application - Global Direct-acting Antiviral Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Direct-acting Antiviral Drugs Market Size, 2021 & 2028
6.2 By Region - Global Direct-acting Antiviral Drugs Revenue & Forecasts
6.2.1 By Region - Global Direct-acting Antiviral Drugs Revenue, 2017-2022
6.2.2 By Region - Global Direct-acting Antiviral Drugs Revenue, 2023-2028
6.2.3 By Region - Global Direct-acting Antiviral Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Direct-acting Antiviral Drugs Revenue, 2017-2028
6.3.2 US Direct-acting Antiviral Drugs Market Size, 2017-2028
6.3.3 Canada Direct-acting Antiviral Drugs Market Size, 2017-2028
6.3.4 Mexico Direct-acting Antiviral Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Direct-acting Antiviral Drugs Revenue, 2017-2028
6.4.2 Germany Direct-acting Antiviral Drugs Market Size, 2017-2028
6.4.3 France Direct-acting Antiviral Drugs Market Size, 2017-2028
6.4.4 U.K. Direct-acting Antiviral Drugs Market Size, 2017-2028
6.4.5 Italy Direct-acting Antiviral Drugs Market Size, 2017-2028
6.4.6 Russia Direct-acting Antiviral Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Direct-acting Antiviral Drugs Market Size, 2017-2028
6.4.8 Benelux Direct-acting Antiviral Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Direct-acting Antiviral Drugs Revenue, 2017-2028
6.5.2 China Direct-acting Antiviral Drugs Market Size, 2017-2028
6.5.3 Japan Direct-acting Antiviral Drugs Market Size, 2017-2028
6.5.4 South Korea Direct-acting Antiviral Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Direct-acting Antiviral Drugs Market Size, 2017-2028
6.5.6 India Direct-acting Antiviral Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Direct-acting Antiviral Drugs Revenue, 2017-2028
6.6.2 Brazil Direct-acting Antiviral Drugs Market Size, 2017-2028
6.6.3 Argentina Direct-acting Antiviral Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Direct-acting Antiviral Drugs Revenue, 2017-2028
6.7.2 Turkey Direct-acting Antiviral Drugs Market Size, 2017-2028
6.7.3 Israel Direct-acting Antiviral Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Direct-acting Antiviral Drugs Market Size, 2017-2028
6.7.5 UAE Direct-acting Antiviral Drugs Market Size, 2017-2028
7 Players Profiles
7.1 AbbVie Inc.
7.1.1 AbbVie Inc. Corporate Summary
7.1.2 AbbVie Inc. Business Overview
7.1.3 AbbVie Inc. Direct-acting Antiviral Drugs Major Product Offerings
7.1.4 AbbVie Inc. Direct-acting Antiviral Drugs Revenue in Global Market (2017-2022)
7.1.5 AbbVie Inc. Key News
7.2 GSK
7.2.1 GSK Corporate Summary
7.2.2 GSK Business Overview
7.2.3 GSK Direct-acting Antiviral Drugs Major Product Offerings
7.2.4 GSK Direct-acting Antiviral Drugs Revenue in Global Market (2017-2022)
7.2.5 GSK Key News
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Corporate Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim Direct-acting Antiviral Drugs Major Product Offerings
7.3.4 Boehringer Ingelheim Direct-acting Antiviral Drugs Revenue in Global Market (2017-2022)
7.3.5 Boehringer Ingelheim Key News
7.4 Merck
7.4.1 Merck Corporate Summary
7.4.2 Merck Business Overview
7.4.3 Merck Direct-acting Antiviral Drugs Major Product Offerings
7.4.4 Merck Direct-acting Antiviral Drugs Revenue in Global Market (2017-2022)
7.4.5 Merck Key News
7.5 Novartis
7.5.1 Novartis Corporate Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Direct-acting Antiviral Drugs Major Product Offerings
7.5.4 Novartis Direct-acting Antiviral Drugs Revenue in Global Market (2017-2022)
7.5.5 Novartis Key News
7.6 Beximco Pharmaceuticals
7.6.1 Beximco Pharmaceuticals Corporate Summary
7.6.2 Beximco Pharmaceuticals Business Overview
7.6.3 Beximco Pharmaceuticals Direct-acting Antiviral Drugs Major Product Offerings
7.6.4 Beximco Pharmaceuticals Direct-acting Antiviral Drugs Revenue in Global Market (2017-2022)
7.6.5 Beximco Pharmaceuticals Key News
7.7 Roche
7.7.1 Roche Corporate Summary
7.7.2 Roche Business Overview
7.7.3 Roche Direct-acting Antiviral Drugs Major Product Offerings
7.7.4 Roche Direct-acting Antiviral Drugs Revenue in Global Market (2017-2022)
7.7.5 Roche Key News
7.8 Bristol-Myers Squibb Company
7.8.1 Bristol-Myers Squibb Company Corporate Summary
7.8.2 Bristol-Myers Squibb Company Business Overview
7.8.3 Bristol-Myers Squibb Company Direct-acting Antiviral Drugs Major Product Offerings
7.8.4 Bristol-Myers Squibb Company Direct-acting Antiviral Drugs Revenue in Global Market (2017-2022)
7.8.5 Bristol-Myers Squibb Company Key News
7.9 Gilead Sciences
7.9.1 Gilead Sciences Corporate Summary
7.9.2 Gilead Sciences Business Overview
7.9.3 Gilead Sciences Direct-acting Antiviral Drugs Major Product Offerings
7.9.4 Gilead Sciences Direct-acting Antiviral Drugs Revenue in Global Market (2017-2022)
7.9.5 Gilead Sciences Key News
7.10 Janssen (Johnson & Johnson)
7.10.1 Janssen (Johnson & Johnson) Corporate Summary
7.10.2 Janssen (Johnson & Johnson) Business Overview
7.10.3 Janssen (Johnson & Johnson) Direct-acting Antiviral Drugs Major Product Offerings
7.10.4 Janssen (Johnson & Johnson) Direct-acting Antiviral Drugs Revenue in Global Market (2017-2022)
7.10.5 Janssen (Johnson & Johnson) Key News
7.11 Vertex Pharmaceuticals
7.11.1 Vertex Pharmaceuticals Corporate Summary
7.11.2 Vertex Pharmaceuticals Business Overview
7.11.3 Vertex Pharmaceuticals Direct-acting Antiviral Drugs Major Product Offerings
7.11.4 Vertex Pharmaceuticals Direct-acting Antiviral Drugs Revenue in Global Market (2017-2022)
7.11.5 Vertex Pharmaceuticals Key News
7.12 Natco Pharma
7.12.1 Natco Pharma Corporate Summary
7.12.2 Natco Pharma Business Overview
7.12.3 Natco Pharma Direct-acting Antiviral Drugs Major Product Offerings
7.12.4 Natco Pharma Direct-acting Antiviral Drugs Revenue in Global Market (2017-2022)
7.12.5 Natco Pharma Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Direct-acting Antiviral Drugs Market Opportunities & Trends in Global Market
Table 2. Direct-acting Antiviral Drugs Market Drivers in Global Market
Table 3. Direct-acting Antiviral Drugs Market Restraints in Global Market
Table 4. Key Players of Direct-acting Antiviral Drugs in Global Market
Table 5. Top Direct-acting Antiviral Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Direct-acting Antiviral Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Direct-acting Antiviral Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Direct-acting Antiviral Drugs Product Type
Table 9. List of Global Tier 1 Direct-acting Antiviral Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Direct-acting Antiviral Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Direct-acting Antiviral Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Direct-acting Antiviral Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Direct-acting Antiviral Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Direct-acting Antiviral Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Direct-acting Antiviral Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Direct-acting Antiviral Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Inc. Corporate Summary
Table 31. AbbVie Inc. Direct-acting Antiviral Drugs Product Offerings
Table 32. AbbVie Inc. Direct-acting Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 33. GSK Corporate Summary
Table 34. GSK Direct-acting Antiviral Drugs Product Offerings
Table 35. GSK Direct-acting Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Boehringer Ingelheim Corporate Summary
Table 37. Boehringer Ingelheim Direct-acting Antiviral Drugs Product Offerings
Table 38. Boehringer Ingelheim Direct-acting Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Merck Corporate Summary
Table 40. Merck Direct-acting Antiviral Drugs Product Offerings
Table 41. Merck Direct-acting Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Novartis Corporate Summary
Table 43. Novartis Direct-acting Antiviral Drugs Product Offerings
Table 44. Novartis Direct-acting Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Beximco Pharmaceuticals Corporate Summary
Table 46. Beximco Pharmaceuticals Direct-acting Antiviral Drugs Product Offerings
Table 47. Beximco Pharmaceuticals Direct-acting Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Roche Corporate Summary
Table 49. Roche Direct-acting Antiviral Drugs Product Offerings
Table 50. Roche Direct-acting Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Bristol-Myers Squibb Company Corporate Summary
Table 52. Bristol-Myers Squibb Company Direct-acting Antiviral Drugs Product Offerings
Table 53. Bristol-Myers Squibb Company Direct-acting Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Gilead Sciences Corporate Summary
Table 55. Gilead Sciences Direct-acting Antiviral Drugs Product Offerings
Table 56. Gilead Sciences Direct-acting Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 57. Janssen (Johnson & Johnson) Corporate Summary
Table 58. Janssen (Johnson & Johnson) Direct-acting Antiviral Drugs Product Offerings
Table 59. Janssen (Johnson & Johnson) Direct-acting Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 60. Vertex Pharmaceuticals Corporate Summary
Table 61. Vertex Pharmaceuticals Direct-acting Antiviral Drugs Product Offerings
Table 62. Vertex Pharmaceuticals Direct-acting Antiviral Drugs Revenue (US$, Mn), (2017-2022)
Table 63. Natco Pharma Corporate Summary
Table 64. Natco Pharma Direct-acting Antiviral Drugs Product Offerings
Table 65. Natco Pharma Direct-acting Antiviral Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Direct-acting Antiviral Drugs Segment by Type in 2021
Figure 2. Direct-acting Antiviral Drugs Segment by Application in 2021
Figure 3. Global Direct-acting Antiviral Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Direct-acting Antiviral Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Direct-acting Antiviral Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Direct-acting Antiviral Drugs Revenue in 2021
Figure 8. By Type - Global Direct-acting Antiviral Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Direct-acting Antiviral Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Direct-acting Antiviral Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Direct-acting Antiviral Drugs Revenue Market Share, 2017-2028
Figure 12. US Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Direct-acting Antiviral Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Direct-acting Antiviral Drugs Revenue Market Share, 2017-2028
Figure 24. China Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Direct-acting Antiviral Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Direct-acting Antiviral Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Direct-acting Antiviral Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Inc. Direct-acting Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GSK Direct-acting Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Boehringer Ingelheim Direct-acting Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck Direct-acting Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis Direct-acting Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Beximco Pharmaceuticals Direct-acting Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Roche Direct-acting Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bristol-Myers Squibb Company Direct-acting Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Gilead Sciences Direct-acting Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Janssen (Johnson & Johnson) Direct-acting Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Vertex Pharmaceuticals Direct-acting Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Natco Pharma Direct-acting Antiviral Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Industry Market Size
